Applied BioCode Corporation: Q4 2025 EPS of -NT$1.96
Applied BioCode Corporation announced its Q4 2025 financial results, reporting an EPS of -NT$1.96, revenue of NT$0.475 billion, and a net loss of NT$0.201 billion, indicating significant R&D investment and potential future growth.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 19, 2026 at 03:34 (283h 34m after Collected)
Company Code: 6598
Company Name: Applied BioCode Corporation
Industry: Biotechnology and Healthcare Industry
Year/Quarter: 2025 Q4
Basic Earnings Per Share: -NT$1.96
Operating Revenue: NT$0.475 billion
Net Profit After Tax: -NT$0.201 billion
Company Name: Applied BioCode Corporation
Industry: Biotechnology and Healthcare Industry
Year/Quarter: 2025 Q4
Basic Earnings Per Share: -NT$1.96
Operating Revenue: NT$0.475 billion
Net Profit After Tax: -NT$0.201 billion
FAQ
What was Applied BioCode Corporation's EPS for the 4th quarter of 2025?
EPS was -1.96 yuan.
What were the operating revenue and net loss after tax for the same quarter?
Operating revenue was 475 million yuan, and net loss after tax was 201 million yuan.
Which industry does this company belong to?
It belongs to the biotechnology and medical industry.